8-K: Marpai Appoints John Powers as President and COO, Restructures Executive Compensation

Marpai, Inc. has appointed John Powers as President and Chief Operating Officer, while also restructuring executive compensation and addressing the departure of the former COO.

Summary

• Marpai, Inc. appointed John Powers as President and Chief Operating Officer, effective January 2, 2024.
• John Powers' annual salary is set at $150,000, with eligibility for bonuses and equity grants.
• Powers received a grant of 150,000 restricted stock units (RSUs) that vest over two years, with 30% vesting immediately, 35% after one year, and 35% after two years.
• If Marpai achieves $5 million in unadjusted EBITDA within a calendar year, Powers will be recommended for an additional 100,000 RSUs with immediate vesting.
• The company also entered into new employment agreements with CEO Damien Lamendola and CFO Steve Johnson, both effective January 2, 2024.
• Damien Lamendola's annual salary is $1.00, and he received 600,000 RSUs vesting over two years, with a potential additional 100,000 RSUs upon achieving the $5 million EBITDA target.
• Steve Johnson's annual salary is $35,568, and he received 350,000 RSUs vesting over two years, with a potential additional 100,000 RSUs upon achieving the $5 million EBITDA target.
• Gonen Antebi, the former COO, resigned on January 15, 2024, with his employment ending on January 24, 2024.
• Antebi received a warrant to purchase 130,000 shares at $2.50 per share, exercisable from January 31, 2024, to January 31, 2029, as part of his separation agreement.
• Marpai entered into a consulting agreement with Gonen Antebi, effective February 1, 2024, for a monthly retainer of $5,000, with certain stock options continuing to vest.

Sentiment

Score: 4

Explanation: While the appointment of a new President and COO is positive, the unusual compensation structure for the CEO and CFO, along with the departure of the former COO, raises concerns about the company's financial health and stability. The sentiment is therefore cautiously negative.

Positives

• The appointment of John Powers as President and COO brings an experienced healthcare benefits executive to the company.
• The new executive compensation structure includes performance-based equity grants tied to achieving $5 million in unadjusted EBITDA, aligning management interests with company performance.
• The consulting agreement with the former COO, Gonen Antebi, ensures a smooth transition and continued access to his expertise.
• The company has secured a new President and COO with a strong track record of driving savings for clients.

Negatives

• The resignation of the former COO, Gonen Antebi, indicates a significant leadership change.
• The CEO's salary of $1.00 per year is unusual and may raise questions about the company's financial stability or management's confidence in the company's future.
• The CFO's salary of $35,568 per year is also unusually low for a public company and may raise questions about the company's financial stability or management's confidence in the company's future.

Risks

• The company's ability to achieve the $5 million unadjusted EBITDA target is uncertain, which could impact the vesting of additional equity grants.
• The departure of the former COO could create operational challenges during the transition period.
• The low salaries for the CEO and CFO may indicate financial constraints or a lack of confidence in the company's future performance.
• The company's reliance on equity grants as a significant part of executive compensation may dilute shareholder value.

Future Outlook

The company aims to achieve rapid efficiencies in operations, improve benefit savings for clients, and become a high-growth, cash flow positive company with a strong track record of innovation.

Management Comments

• John Powers stated that Marpai's robust data analytics, combined with industry-leading partnerships and recent leadership changes, was extremely compelling.
• Damien Lamendola, Chief Executive Officer, commented that John Powers' leadership and business acumen are critical to strengthening the company's foundation and positioning it for its next growth phase.

Industry Context

The appointment of John Powers, a seasoned healthcare benefits executive, reflects Marpai's focus on strengthening its position in the competitive third-party administration (TPA) market. The company is aiming to capitalize on the $22 billion TPA sector serving self-funded employer health plans.

Comparison to Industry Standards

• The appointment of a President and COO is a common practice in growing companies to manage operations and drive strategic initiatives, similar to moves made by companies like Accolade and Quantum Health.
• The use of restricted stock units (RSUs) as part of executive compensation is standard practice in the industry, aligning executive interests with shareholder value, similar to compensation packages at companies like Teladoc Health and Livongo.
• The CEO's salary of $1.00 is highly unusual and deviates significantly from industry norms, where CEOs of public companies typically receive substantial base salaries and performance-based bonuses. This is unlike companies such as UnitedHealth Group or CVS Health where executive compensation is typically in the millions.
• The CFO's salary of $35,568 is also significantly below industry standards for public companies, where CFOs typically earn hundreds of thousands of dollars annually, similar to CFOs at companies like Anthem and Humana.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the low salaries for the CEO and CFO, which could indicate financial instability.
• Employees may experience changes in leadership and operational processes with the new appointments.
• Customers may benefit from the company's focus on improving benefit savings opportunities.
• Suppliers and creditors may be impacted by the company's financial performance and ability to meet its obligations.

Next Steps

• The company will implement the new executive employment agreements.
• The company will work towards achieving the $5 million unadjusted EBITDA target to trigger additional equity grants.
• The company will integrate John Powers into his new role as President and COO.
• The company will continue to execute its strategic initiatives for growth and operational efficiency.

Key Dates

Keywords

executive appointment, chief operating officer, president, executive compensation, restricted stock units, EBITDA, separation agreement, consulting agreement, healthcare benefits, third-party administration